Ajanta Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Ajanta Pharma Ltd. on BSE

Load latest

Ajanta Pharma Ltd.

28 Jul 2022

2542.80

-0.27%

Board Meeting

AJANTA PHARMA LTD. - 532331 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following: i. Press Release being issued on the Results for the quarter ended 30th June 2022; ii. Unaudited Consolidated Financial Results for the quarter ended 30th June 2022; iii. Limited Review Report from Auditors, M/s B S R & Co. LLP, on the unaudited Consolidated Financial Results for the quarter ended 30th June 2022; iv. Unaudited Standalone Financial Results for the quarter ended 30th June 2022; v. Limited Review Report from Auditors, M/s B S R & Co. LLP, on the unaudited Standalone Financial Results for the quarter ended 30th June 2022; vi. Investors' presentation. Kindly note that the meeting of the Board of Directors commenced at 2.00 p.m. and concluded at 3.50 p.m. and take the above on your records.

pdf

Ajanta Pharma Ltd.

27 Jul 2022

2542.80

-0.27%

Corp. Note

AJANTA PHARMA LTD. - 532331 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Information on loss of shares

pdf

Ajanta Pharma Ltd.

21 Jul 2022

2542.80

-0.27%

Company Update

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 28th July 2022, post Board meeting. This is for your information and records please.

pdf

Ajanta Pharma Ltd.

20 Jul 2022

2542.80

-0.27%

Board Meeting

AJANTA PHARMA LTD. - 532331 - Board Meeting Intimation for Considering And Approving Unaudited Consolidated And …

BSE India

AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2022 ,inter alia, to consider and approve Unaudited consolidated and standalone financial results of the Company for the first quarter ended 30th June 2022.

pdf

Ajanta Pharma Ltd.

13 Jul 2022

2542.80

-0.27%

SAST

AJANTA PHARMA LTD. - 532331 - Updates on Disclosures under Reg. 31(1) and 31(2) of SEBI …

BSE India

The Exchange has received Updates on Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 12, 2022 for Ravi P Agrawal, trustee Ravi Agrawal Trust

pdf

Ajanta Pharma Ltd.

13 Jul 2022

2542.80

-0.27%

Company Update

AJANTA PHARMA LTD. - 532331 - Statement Of Investor Complaints For The Quarter Ended June 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Gaurang ShahDesignation :- Company Secretary and Compliance Officer

Ajanta Pharma Ltd.

13 Jul 2022

2542.80

-0.27%

Company Update

AJANTA PHARMA LTD. - 532331 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

We are pleased to enclose herewith certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2022 received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company.

pdf

Ajanta Pharma Ltd.

07 Jul 2022

2542.80

-0.27%

Company Update

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers regarding e-voting information for the 43rd Annual General Meeting of the Company in terms of Section 108 of the Companies Act, 2013 read with Rule 20 of Companies (Management and Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in the following newspapers on 7th July 2022: 1. Mumbai edition of Economic Times; 2. Mumbai edition of Navshakti. Please take in on your record.

pdf

Ajanta Pharma Ltd.

06 Jul 2022

2542.80

-0.27%

Corp. Note

AJANTA PHARMA LTD. - 532331 - Reg. 34 (1) Annual Report.

BSE India

We hereby inform that the Forty-Third Annual General Meeting ('AGM') of the Company will be held on Thursday, 4th August 2022 at 11.00 a.m. through Video Conferencing or Other Audio-Visual Means. Pursuant to Regulation 34(1) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report and Business Responsibility & Sustainability Report of the Company for the financial year 2021-22 along with Notice of the AGM. The Annual report, Business Responsibility & Sustainability Report and the Notice of AGM are being sent to the members through electronic mode and the same are also uploaded on the Company''s website http://www.ajantapharma.com/AnnualReports.aspx. Kindly take the same on your records.

pdf

Ajanta Pharma Ltd.

04 Jul 2022

2542.80

-0.27%

Company Update

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers in terms of Circular No. 20/2020 dated 5th May 2020 issued by Ministry of Corporate Affairs, inter-alia, intimating that 43rd Annual General Meeting of the Company will be held on 4th August 2022 through Video Conferencing/Other Audio-Visual Means, in the following newspapers on 2nd July 2022: 1. Mumbai edition of Economic Times; 2. Mumbai edition of Navshakti. Please take in on your record.

pdf

Is Ajanta Pharma Ltd. worth buying?

189 Votes:

Buy 77.25%

Sell 15.87%

Hold 6.88%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf